Curbs Return News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Curbs return. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Curbs Return Today - Breaking & Trending Today
India Has 2nd-Most Cases; U.K. Hits Vaccine Target: Virus Update Bloomberg 2 hrs ago Bloomberg News (Bloomberg) India overtook Brazil as the country with the second-most cases in the world. A study in Brazil showed that Sinovac Biotech Ltd.’s vaccine is slightly more than 50% effective, raising new concerns over the efficacy of the China’s suite of Covid-19 shots. The U.K. hit its goal of offering a shot to all those over 50 three days early. England reopened shops, pub gardens, gyms and hair salons after months of lockdown, even as the Mayor of London called for wider testing in two city boroughs following a new outbreak. ....
India Has 2nd-Most Cases; Indonesia Keeps Sinovac: Virus Update Bloomberg 59 mins ago Bloomberg News (Bloomberg) India overtook Brazil as the country with the second-most cases in the world. Indonesia is sticking with Sinovac Biotech Ltd.’s vaccine even as a study raised new concerns over the efficacy of the China’s suite of Covid-19 shots. Italy is in talks to set up vaccine production hubs as the government seeks to build up domestic capacity amid concern the country risks missing its latest target for inoculations. The U.K. hit its goal of offering a shot to all those over 50 three days early while England reopened shops, pub gardens, gyms and hair salons after months of lockdown. The weekly death toll from Covid-19 in the U.S. rose for the first time since February and infections climbed for a fourth straight week, despite surging vaccinations. ....
U.S. health officials recommended a pause in the use of Johnson & Johnson’s vaccine on concerns about rare and severe blood-clotting side effects. ....
The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe. ....
U.S. health officials recommended a pause in the use of Johnson & Johnson’s vaccine on concerns about rare and severe blood-clotting side effects. ....